Randomized, Prospective, Controlled Study Comparing Radical Prostatectomy Alone and Neoadjuvant Androgen Withdrawal in the Treatment of Localized Prostate Cancer-Reference-Cited by-同舟云学术

Randomized, Prospective, Controlled Study Comparing Radical Prostatectomy Alone and Neoadjuvant Androgen Withdrawal in the Treatment of Localized Prostate Cancer

Published:1996-09 Issue:3 Volume:156 Page:873-877
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Goldenberg S. Larry¹,Klotz Laurence H.¹,Srigley John¹,Jewett Michael A.S.¹,Mador David¹,Fradet Yves¹,Barkin Jack¹,Chin Joseph¹,Paquin Jean-Marie¹,Bullock Martin J.¹,Laplante Suzanne¹

Affiliation:

1. From the Division of Urology, University of British Columbia, Vancouver, British Columbia, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference24 articles.

1. Frequency and location of extracapsular extension and positive surgical margins in radical prostatectomy specimens;Rosen;J. Urol.,1992

2. Understaging and undergrading of prostate cancer. Argument for postoperative radiation as adjuvant treatment;Lange;Urology,1983

3. Role of nerve-sparing radical prostatectomy for clinical stage B2 prostate cancer;Bigg;J. Urol.,1990

4. Postoperative radiotherapy for patients with carcinoma of the prostate undergoing radical prostatectomy with positive surgical margins, seminal vesicle involvement and/or penetration through the capsule;Anscher;J. Urol.,1987

5. Surgical treatment of locally advanced (T3) prostatic carcinoma: early results;Bosch;J. Urol.,1987

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative Morbidity of Radical Prostatectomy After Intensive Neoadjuvant Androgen Blockade in Men With High-Risk Prostate Cancer: Results of Phase II Trial Compared to a Control Group;Clinical Genitourinary Cancer;2023-02

2. Quality rectal hydrogel placement allows for gel-enabled dose-escalated EBRT (GEDE-EBRT) without rectal interference in prostate cancer;Medical Dosimetry;2023

3. Neoadjuvant Hormonal Therapy for Prostate Cancer: Morphologic Features and Predictive Parameters of Therapy Response;Advances in Anatomic Pathology;2022-04-13

4. Neoadjuvant Systemic Therapy Prior to Radical Prostatectomy for Clinically Localized High-Risk Prostate Cancer;Frontiers in Urology;2022-03-10

5. Co-Inhibition of Androgen Receptor and PARP as a Novel Treatment Paradigm in Prostate Cancer—Where Are We Now?;Cancers;2022-02-04